Amurensin G enhances the susceptibility to tumor necrosis factor-related apoptosis-inducing ligand-mediated cytotoxicity of cancer stem-like cells of HCT-15 cells (Q39080597)

From Wikidata

Jump to navigation Jump to search

scientific article published on 12 November 2013

Language	Label	Description	Also known as
English	Amurensin G enhances the susceptibility to tumor necrosis factor-related apoptosis-inducing ligand-mediated cytotoxicity of cancer stem-like cells of HCT-15 cells	scientific article published on 12 November 2013

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Amurensin G enhances the susceptibility to tumor necrosis factor-related apoptosis-inducing ligand-mediated cytotoxicity of cancer stem-like cells of HCT-15 cells (English)

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

0 references

author name string

Su-Hoon Lee

1

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Mi-Ju Kim

2

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Dong-Wan Kim

3

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Chi-Dug Kang

4

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Sun-Hee Kim

5

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

publication date

12 November 2013

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

104

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

12

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

1632-1639

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Cancer stem cells: mirage or reality?

1 reference

https://api.crossref.org/works/10.1111%2FCAS.12299

21 January 2018

CD44+ CD24(-) prostate cells are early cancer progenitor/stem cells that provide a model for patients with poor prognosis

1 reference

https://api.crossref.org/works/10.1111%2FCAS.12299

21 January 2018

The Emerging Picture of Human Breast Cancer as a Stem Cell-based Disease.

1 reference

https://api.crossref.org/works/10.1111%2FCAS.12299

21 January 2018

Stem cells in mammary development and carcinogenesis: implications for prevention and treatment

1 reference

https://api.crossref.org/works/10.1111%2FCAS.12299

21 January 2018

Intrinsic resistance of tumorigenic breast cancer cells to chemotherapy

1 reference

https://api.crossref.org/works/10.1111%2FCAS.12299

21 January 2018

Survival of the fittest: cancer stem cells in therapeutic resistance and angiogenesis

1 reference

https://api.crossref.org/works/10.1111%2FCAS.12299

21 January 2018

Exploring the role of cancer stem cells in radioresistance

1 reference

https://api.crossref.org/works/10.1111%2FCAS.12299

21 January 2018

Identification and expansion of human colon-cancer-initiating cells

1 reference

https://api.crossref.org/works/10.1111%2FCAS.12299

21 January 2018

A human colon cancer cell capable of initiating tumour growth in immunodeficient mice

1 reference

https://api.crossref.org/works/10.1111%2FCAS.12299

21 January 2018

Cancer stem cells from colorectal cancer-derived cell lines.

1 reference

https://api.crossref.org/works/10.1111%2FCAS.12299

21 January 2018

Aldehyde dehydrogenase 1 is a marker for normal and malignant human colonic stem cells (SC) and tracks SC overpopulation during colon tumorigenesis

1 reference

https://api.crossref.org/works/10.1111%2FCAS.12299

21 January 2018

Single-cell cloning of colon cancer stem cells reveals a multi-lineage differentiation capacity.

1 reference

https://api.crossref.org/works/10.1111%2FCAS.12299

21 January 2018

Cancer stem cell markers in common cancers - therapeutic implications

1 reference

https://api.crossref.org/works/10.1111%2FCAS.12299

21 January 2018

Cancer stem cells: Invitation to a second round

1 reference

https://api.crossref.org/works/10.1111%2FCAS.12299

21 January 2018

Early cellular events in colorectal carcinogenesis.

1 reference

https://api.crossref.org/works/10.1111%2FCAS.12299

21 January 2018

A genetic model for colorectal tumorigenesis

1 reference

https://api.crossref.org/works/10.1111%2FCAS.12299

21 January 2018

Crypt stem cells as the cells-of-origin of intestinal cancer

1 reference

https://api.crossref.org/works/10.1111%2FCAS.12299

21 January 2018

Stem cells, cancer, and cancer stem cells

1 reference

https://api.crossref.org/works/10.1111%2FCAS.12299

21 January 2018

Transcriptional regulation and transformation by Myc proteins

1 reference

https://api.crossref.org/works/10.1111%2FCAS.12299

21 January 2018

c-Myc in breast cancer

1 reference

https://api.crossref.org/works/10.1111%2FCAS.12299

21 January 2018

Identification of c-MYC as a target of the APC pathway

1 reference

https://api.crossref.org/works/10.1111%2FCAS.12299

21 January 2018

Synthetic lethal targeting of MYC by activation of the DR5 death receptor pathway

1 reference

https://api.crossref.org/works/10.1111%2FCAS.12299

21 January 2018

Cell surface Death Receptor signaling in normal and cancer cells

1 reference

https://api.crossref.org/works/10.1111%2FCAS.12299

21 January 2018

Targeting death and decoy receptors of the tumour-necrosis factor superfamily

1 reference

https://api.crossref.org/works/10.1111%2FCAS.12299

21 January 2018

Amurensin G, a potent natural SIRT1 inhibitor, rescues doxorubicin responsiveness via down-regulation of multidrug resistance 1

1 reference

https://api.crossref.org/works/10.1111%2FCAS.12299

21 January 2018

Characterization of a subpopulation of colon cancer cells with stem cell-like properties

1 reference

https://api.crossref.org/works/10.1111%2FCAS.12299

21 January 2018

Optimization of glioblastoma multiforme stem cell isolation, transfection, and transduction

1 reference

https://api.crossref.org/works/10.1111%2FCAS.12299

21 January 2018

ABC transporters in cancer: more than just drug efflux pumps.

1 reference

https://api.crossref.org/works/10.1111%2FCAS.12299

21 January 2018

Involvement of SIRT1 in hypoxic down-regulation of c-Myc and β-catenin and hypoxic preconditioning effect of polyphenols

1 reference

https://api.crossref.org/works/10.1111%2FCAS.12299

21 January 2018

Cell aggregates in the soft agar “human tumour stem-cell assay”

1 reference

https://api.crossref.org/works/10.1111%2FCAS.12299

21 January 2018

Primary Bioassay of Human Tumor Stem Cells

1 reference

https://api.crossref.org/works/10.1111%2FCAS.12299

21 January 2018

The Wnt/beta-catenin pathway regulates growth and maintenance of colonospheres

1 reference

https://api.crossref.org/works/10.1111%2FCAS.12299

21 January 2018

ABC transporters, drug resistance, and cancer stem cells

1 reference

https://api.crossref.org/works/10.1111%2FCAS.12299

21 January 2018

TRAIL sensitize MDR cells to MDR-related drugs by down-regulation of P-glycoprotein through inhibition of DNA-PKcs/Akt/GSK-3beta pathway and activation of caspases

1 reference

https://api.crossref.org/works/10.1111%2FCAS.12299

21 January 2018

Leukemia-initiating cells of patient-derived acute lymphoblastic leukemia xenografts are sensitive toward TRAIL.

1 reference

https://api.crossref.org/works/10.1111%2FCAS.12299

21 January 2018

Basal-like breast cancer stem cells are sensitive to anti-DR5 mediated cytotoxicity

1 reference

https://api.crossref.org/works/10.1111%2FCAS.12299

21 January 2018

CD133-positive cells are resistant to TRAIL due to up-regulation of FLIP.

1 reference

https://api.crossref.org/works/10.1111%2FCAS.12299

21 January 2018

Stem-cell-like glioma cells are resistant to TRAIL/Apo2L and exhibit down-regulation of caspase-8 by promoter methylation

1 reference

https://api.crossref.org/works/10.1111%2FCAS.12299

21 January 2018

High susceptibility of metastatic cells derived from human prostate and colon cancer cells to TRAIL and sensitization of TRAIL-insensitive primary cells to TRAIL by 4,5-dimethoxy-2-nitrobenzaldehyde

1 reference

https://api.crossref.org/works/10.1111%2FCAS.12299

21 January 2018

Mechanisms of cancer drug resistance

1 reference

https://api.crossref.org/works/10.1111%2FCAS.12299

21 January 2018

Multidrug Efflux Pumps and Cancer Stem Cells: Insights Into Multidrug Resistance and Therapeutic Development

1 reference

https://api.crossref.org/works/10.1111%2FCAS.12299

21 January 2018

Chemotherapy-resistant side-population of colon cancer cells has a higher sensitivity to TRAIL than the non-SP, a higher expression of c-Myc and TRAIL-receptor DR4

1 reference

https://pubmed.ncbi.nlm.nih.gov/24118446

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tumor growth need not be driven by rare cancer stem cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/24118446

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Formation of spherical colonies as a property of stem cells]

1 reference

https://pubmed.ncbi.nlm.nih.gov/24118446

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Amurensin G, a novel SIRT1 inhibitor, sensitizes TRAIL-resistant human leukemic K562 cells to TRAIL-induced apoptosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/24118446

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1111/CAS.12299

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39080597&oldid=1806908295"